Test of 20 journals – Mary Ann Liebert from 12 September to 6 November 2022

Mary Ann Liebert, founded in 1980, publishes more than 90 journals focused on biotechnology, biomedical research, medicine and surgery, public health research and policy, technology and engineering.

Mary Ann Liebert’s mission through its journals is to advance research and development, foster collaborations that enable the best therapeutic options, and ultimately improve patient care.

A selection of 20 Mary Ann Liebert journals is available for a 2-month trial period.

 

• AIDS Research and Human Retroviruses
• Antioxidants & Redox Signaling
• Astrobiology
• DNA and Cell Biology
• Genetic Engineering & Biotechnology News
• Human Gene Therapy
• Journal of Computational Biology
• Journal of Correctional Health Care
• Journal of Neurotrauma
• Journal of Women’s Health
• Microbial Drug Resistance
• OMICS: A Journal of Integrative Biology
• Population Health Management
• Soft Robotics
• Stem Cells and Development
• Sustainability and Climate Change
• The CRISPR Journal
• Thyroid, Clinical Thyroidology and VideoEndocrinology
• Tissue Engineering, Parts A, B, and C
• Viral Immunology